VV
GILD icon

Verity & Verity’s Gilead Sciences GILD Stock Holding History

Verity & Verity’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.4M Buy
272,652
+268
+0.1% +$35.3K 2.37% 10
2026
Q1 		$38M Buy
272,384
+776
+0.3% +$109K 2.83% 4
2025
Q4 		$33.3M Buy
271,608
+909
+0.3% +$110K 2.59% 8
2025
Q3 		$30M Sell
270,699
-13,079
-5% -$1.49M 2.4% 10
2025
Q2 		$31.5M Sell
283,778
-43,792
-13% -$4.66M 2.7% 6
2025
Q1 		$36.7M Sell
327,570
-50,532
-13% -$5.21M 3.22% 1
2024
Q4 		$34.9M Buy
378,102
+10,771
+3% +$970K 3.19% 2
2024
Q3 		$30.8M Buy
367,331
+2,250
+0.6% +$172K 3.02% 3
2024
Q2 		$25M Buy
365,081
+36,263
+11% +$2.42M 2.73% 8
2024
Q1 		$24.1M Sell
328,818
-13,728
-4% -$1.06M 2.68% 6
2023
Q4 		$27.7M Buy
342,546
+1,239
+0.4% +$96.4K 3.18% 3
2023
Q3 		$25.6M Buy
341,307
+4,131
+1% +$318K 3.2% 2
2023
Q2 		$26M Buy
337,176
+17,453
+5% +$1.39M 3.19% 5
2023
Q1 		$26.5M Buy
319,723
+3,706
+1% +$307K 3.39% 1
2022
Q4 		$27.1M Sell
316,017
-3,580
-1% -$284K 3.54% 1
2022
Q3 		$19.7M Buy
319,597
+9,959
+3% +$628K 3.17% 1
2022
Q2 		$19.1M Sell
309,638
-3,003
-1% -$186K 2.93% 3
2022
Q1 		$18.6M Buy
312,641
+102,665
+49% +$6.56M 2.58% 6
2021
Q4 		$15.2M Buy
209,976
+5,053
+2% +$348K 2.18% 12
2021
Q3 		$13.8M Buy
204,923
+9,032
+5% +$635K 2.07% 14
2021
Q2 		$13.5M Hold
195,891
– – 2.13% 10
2021
Q1 		$13M Buy
195,891
+43,431
+28% +$2.8M 2.11% 11
2020
Q4 		$9.53M Buy
152,460
+19,497
+15% +$1.18M 1.8% 20
2020
Q3 		$8.46M Buy
132,963
+38,200
+40% +$2.65M 1.86% 17
2020
Q2 		$7.27M Buy
94,763
+1,992
+2% +$153K 1.73% 25
2020
Q1 		$6.94M Buy
92,771
+32,490
+54% +$2.25M 1.95% 18
2019
Q4 		$3.92M Buy
60,281
+35,721
+145% +$2.33M 0.76% 51
2019
Q3 		$1.52M Buy
+24,560
New +$1.61M 0.32% 77

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verity & Verity's GILD Position: Q2 2026 in Review

Verity & Verity increased its Gilead Sciences (GILD) stake by 0.1% in Q2 2026, buying an estimated $35.3K and bringing the position to 272,652 shares worth $34.4M. The position accounts for 2.37% of the portfolio, ranked #10.

Verity & Verity first reported a position in GILD in Q3 2019 and has held it in 28 quarters since. The position peaked at $38M in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Verity & Verity held 272,652 shares of Gilead Sciences worth $34.4M as of Q2 2026.
  • Verity & Verity bought 268 Gilead Sciences shares in Q2 2026, an estimated $35.3K.
  • Gilead Sciences made up 2.37% of Verity & Verity's portfolio in Q2 2026, its #10 holding.
  • Verity & Verity first reported a position in Gilead Sciences in Q3 2019 and has held it in 28 quarters since.
  • Verity & Verity's Gilead Sciences position peaked at $38M in Q1 2026.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Verity & Verity's 13F filing for Q2 2026, filed 28 Jul 2026.